Gulf Coast Research, LLC

Lafayette, Louisiana 70508

0 studies enrolling now · 6 studies all time

What they study most

Acute Gout, COPD, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Type 2, Influenza, Lung Diseases, Obstructive, Opioid-Induced Bowel Dysfunction, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza — Stopped early
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes — Completed
• Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone — Completed
• Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed